INGALLS & SNYDER LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
INGALLS & SNYDER LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q1 2020$189,000
-75.1%
13,185
-52.7%
0.01%
-68.3%
Q4 2019$758,000
-42.4%
27,854
-39.4%
0.04%
-35.9%
Q3 2019$1,315,000
-4.8%
45,929
-7.7%
0.06%
-3.0%
Q2 2019$1,382,000
-16.3%
49,743
-0.0%
0.07%
-16.5%
Q1 2019$1,652,000
+14.7%
49,746
+0.4%
0.08%
+3.9%
Q4 2018$1,440,000
-36.0%
49,526
+1.2%
0.08%
-20.0%
Q3 2018$2,250,000
+22.7%
48,921
-0.3%
0.10%
+11.8%
Q2 2018$1,833,000
+26.3%
49,046
-0.1%
0.08%
+19.7%
Q1 2018$1,451,000
-13.9%
49,0990.0%0.07%
-9.0%
Q4 2017$1,686,000
-13.0%
49,099
-8.4%
0.08%
-22.8%
Q3 2017$1,939,000
+40.9%
53,599
+0.7%
0.10%
+34.7%
Q2 2017$1,376,000
+32.2%
53,249
-1.8%
0.08%
+33.9%
Q1 2017$1,041,000
+3.9%
54,224
-9.8%
0.06%
+1.8%
Q4 2016$1,002,000
-53.7%
60,084
-42.8%
0.06%
-54.5%
Q3 2016$2,162,000
-48.4%
105,071
-23.3%
0.12%
-51.0%
Q2 2016$4,193,000137,0120.25%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders